Catella AB
STO:CAT B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Catella AB
STO:CAT B
|
SE |
|
Gyldendal ASA
OSE:GYL
|
NO |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
US |
|
MPLX LP
NYSE:MPLX
|
US |
|
G
|
G.S. Auto International Ltd
BSE:513059
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CAT B's stock price target?
Not Available
CAT B doesn't have any price targets made by Wall Street professionals.
What is Catella AB's Revenue forecast?
Projected CAGR
5%
For the last 9 years the
compound annual growth rate for
Catella AB's revenue is
0%.
The projected
CAGR
for the next 3 years is
5%.
What is Catella AB's Operating Income forecast?
Projected CAGR
4%
For the last 9 years the
compound annual growth rate for
Catella AB's operating income is
3%.
The projected
CAGR
for the next 3 years is
4%.
What is Catella AB's Net Income forecast?
Projected CAGR
67%
For the last 9 years the
compound annual growth rate for
Catella AB's net income is
-18%.
The projected
CAGR
for the next 3 years is
67%.